Invention Application
- Patent Title: AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY
-
Application No.: US17004447Application Date: 2020-08-27
-
Publication No.: US20210147522A1Publication Date: 2021-05-20
- Inventor: Pekka KALLUNKI , Karina FOG , Louise Buur VESTERAGER , Ann-Louise BERGSTRÔM , Florence SOTTY , David SATIJN , Edward VAN DEN BRINK , Paul PARREN , Rik RADEMAKER , Tom VINK , Ibrahim John MALIK , Liliana Christina Pereira MONTEZINHO
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Priority: GB1512203.9 20150713
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K51/00 ; A61K39/395 ; A61P25/16 ; A61P25/28 ; G01N33/68
Abstract:
The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
Public/Granted literature
- US11421024B2 Agents, uses and methods for the treatment of synucleinopathy Public/Granted day:2022-08-23
Information query
